Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUS

Clinical trial NCT04132375 · TERMINATED

Trial details

NCT number: NCT04132375
Sponsor: Inmunova S.A.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Bloody Diarrhea STEC, Unspecified Hemolytic-Uremic Syndrome Pediatric Kidney Disease

Start date: 2019-07-17
Primary completion: 2022-05-04
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.